- Home
- HURA vs FMAC Comparison
HURA vs FMAC Comparison
Compare HURA & FMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HURA | FMAC |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 157.5M |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | HURA | FMAC |
|---|---|---|
| Price | $2.34 | $9.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 718.2K | 3.4K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $9.96 |
| 52 Week High | $3.90 | $10.02 |
Technical Indicators
Market Signals| Indicator | HURA | FMAC |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 46.43 |
| Support Level | $2.09 | N/A |
| Resistance Level | $2.71 | N/A |
| Average True Range (ATR) | 0.22 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 36.43 | 28.57 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About FMAC Future Money Acquisition Corporation Ordinary Shares
Future Money Acquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.